Immuneering Corporation - Class A —— 资产负债表 (NASDAQ:IMRX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 166.7 M122.37 M102.58 M52.71 M231.99 M 负债总额 10.72 M12.52 M12.01 M11.33 M13.5 M 权益总额 155.98 M109.85 M90.58 M41.39 M218.48 M 负债及股东权益总额 166.7 M122.37 M102.58 M52.71 M231.99 M 总债务 ————— 净债务 —————

新闻

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts - TipRanks.com

Piper Sandler因上市时间调整下调Immuneering目标价

Piper Sandler cuts Immuneering stock price target on launch timing

Oppenheimer维持Immuneering股票评级,看好管线进展

Oppenheimer reiterates Immuneering stock rating on pipeline progress

Immuneering’s (IMRX) chief business officer buys $24,990 in stock

Immuneering公司董事Schall购买价值10.1万美元股票

Immuneering首席人力官Neufeld购入价值$10,905的IMRX股票

Immuneering董事Feinberg购入价值8.69万美元股票

Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55%